Trial site
North Georgia Clinical Research
- 22running trials
- 9closed trials
The trials here
What the 31 trials at this site are about, from their registry records.
- Conditions
- Obesity20 trials
- Type 2 diabetes13 trials
- Osteoarthritis8 trials
- Alzheimer disease3 trials
- Type 1 diabetes3 trials
- Chronic kidney disease2 trials
- Coronary artery disease2 trials
- Familial hypercholesterolaemia1 trial
- Heart failure1 trial
- High blood pressure1 trial
- Obstructive sleep apnoea1 trial
- Peripheral artery disease1 trial
- and 1 more
- Phase
- Phase 325 trials
- Phase 26 trials
- Status
- Active, not recruiting12 trials
- Recruiting10 trials
- Completed9 trials
- Lead sponsor
- Eli Lilly and Company22 trials
- Amgen3 trials
- Grünenthal GmbH2 trials
- Alveus Therapeutics, Inc.1 trial
- NewAmsterdam Pharma1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Recruiting
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Recruiting
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity6 recruiting
- Osteoarthritis3 recruiting
- Type 2 diabetes3 recruiting
- Alzheimer disease1 recruiting
- Coronary artery disease1 recruiting
- High blood pressure1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
Completed
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026